Search by Drug Name or NDC

    NDC 00409-1555-54 Hextend 6 g/100mL Details

    Hextend 6 g/100mL

    Hextend is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is HETASTARCH.

    Product Information

    NDC 00409-1555
    Product ID 0409-1555_0f69105e-ffcf-4806-a11d-c9cb88c1c436
    Associated GPIs 85300010402020
    GCN Sequence Number 042851
    GCN Sequence Number Description hetastarch/electrolyt,lactated PLAST. BAG 6 % INTRAVEN
    HIC3 M0D
    HIC3 Description PLASMA EXPANDERS
    GCN 92712
    HICL Sequence Number 020290
    HICL Sequence Number Description HETASTARCH/ELECTROLYTE SOLUTION,LACTATED
    Brand/Generic Generic
    Proprietary Name Hextend
    Proprietary Name Suffix n/a
    Non-Proprietary Name HETASTARCH
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 6
    Active Ingredient Units g/100mL
    Substance Name HETASTARCH
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Increased Intravascular Volume [PE], Osmotic Activity [MoA], Plasma Volume Expander [EPC], Starch [CS]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number BN200952
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-1555-54 (00409155554)

    NDC Package Code 0409-1555-54
    Billing NDC 00409155554
    Package 12 BAG in 1 CASE (0409-1555-54) / 500 mL in 1 BAG (0409-1555-64)
    Marketing Start Date 2005-02-02
    NDC Exclude Flag N
    Pricing Information N/A